Screaming adverse event reports that record this term

Kind of term: MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From January 2004 to June 2026, FDA received 6,298 adverse event reports that record the MedDRA preferred term Screaming. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 322 reports in the 12 months to June 2026 and 368 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

By reports in the 12 months to June 2026, this term was number 1,197 of 1,436 reaction terms with a page. Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 322 (under 0.1%) record this term. Reports for patients aged 2 to 11 were 16.3% of the reports that record this term and 1.4% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 141 drug pages with 10 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Screaming name as a suspect product, in order of name
Drug	Class	Reports with this term
Abilify	Atypical antipsychotic	50
Abilify Maintena		14
Alcohol		20
Alprazolam	Benzodiazepine	10
Altabax		15
Ambien	gamma-Aminobutyric acid A receptor positive modulator	10
Amlodipine	Calcium channel blocker	18
Amoxicillin	Penicillin-class antibacterial	19
Aripiprazole	Atypical antipsychotic	49
Ativan	Benzodiazepine	14
Avonex	Interferon beta	20
Baclofen	gamma-Aminobutyric acid-ergic agonist	18
Benadryl	Histamine-1 receptor antagonist	10
Bromazepam		20
Buprenorphine	Partial opioid agonist	17
Bupropion	Aminoketone	27
Bupropion hydrochloride	Aminoketone	23
Calcium carbonate	Blood coagulation factor	15
Caplyta	Atypical antipsychotic	13
Carbamazepine	Mood stabilizer	13
Carbidopa levodopa	Aromatic amino acid	43
Cetirizine	Histamine-1 receptor antagonist	14
Chantix	Partial cholinergic nicotinic agonist	185
Ciprofloxacin	Fluoroquinolone antibacterial	23
Citalopram	Serotonin reuptake inhibitor	14
Clarithromycin	Macrolide antimicrobial	14
Clonazepam	Benzodiazepine	29
Clozapine	Atypical antipsychotic	35
Clozaril	Atypical antipsychotic	12
Cocaine		14
Codeine		10
Concerta	Central nervous system stimulant	19
Cosentyx	Interleukin-17A antagonist	17
Cymbalta		78
Daybue		139
Daytrana	Central nervous system stimulant	12
Definity	Contrast agent for ultrasound imaging	32
Diazepam	Benzodiazepine	18
Dilaudid	Opioid agonist	12
Duloxetine	Serotonin and norepinephrine reuptake inhibitor	11
Duodopa		23
Dupixent	Interleukin-4 receptor alpha antagonist	56
Effexor	Serotonin and norepinephrine reuptake inhibitor	25
Enbrel	Tumor necrosis factor blocker	56
Epidiolex		35
Ergocalciferol	Provitamin D2 compound	15
Escitalopram	Serotonin reuptake inhibitor	17
Eucrisa	Phosphodiesterase 4 inhibitor	11
Exelon	Cholinesterase inhibitor	31
Fentanyl	Opioid agonist	44
Fintepla		18
Fluoxetine	Serotonin reuptake inhibitor	14
Forteo	Parathyroid hormone analog	29
Gabapentin	Anti-epileptic agent	22
Genotropin		16
Geodon	Atypical antipsychotic	11
Haloperidol	Typical antipsychotic	15
Humira		77
Hydromorphone		21
Ibuprofen	Nonsteroidal anti-inflammatory drug	50
Idursulfase	Hydrolytic lysosomal glycosaminoglycan-specific enzyme	12
Indapamide	Thiazide-like diuretic	12
Invega Sustenna	Atypical antipsychotic	20
Keppra		39
Lamictal	Anti-epileptic agent	29
Lamotrigine	Anti-epileptic agent	28
Latuda	Atypical antipsychotic	43
Levetiracetam		35
Lexapro	Serotonin reuptake inhibitor	17
Lisinopril	Angiotensin converting enzyme inhibitor	10
Lorazepam	Benzodiazepine	70
Lyrica		86
Methylphenidate	Central nervous system stimulant	12
Methylphenidate hydrochloride	Central nervous system stimulant	17
MiraLAX	Osmotic laxative	54
Mirena	Progestin	21
Mirtazapine		37
Montelukast	Leukotriene receptor antagonist	65
Montelukast sodium	Leukotriene receptor antagonist	26
Morphine	Opioid agonist	21
Morphine sulfate	Opioid agonist	21
Namenda		10
Neurontin		11
Nexium	Proton pump inhibitor	15
Nordazepam		14
Nuedexta	Antiarrhythmic	14
Nuplazid	Atypical antipsychotic	188
Olanzapine	Atypical antipsychotic	29
Omeprazole	Proton pump inhibitor	14
Omnitrope	Recombinant human growth hormone	15
Oseltamivir phosphate	Neuraminidase inhibitor	12
Oxazepam	Benzodiazepine	14
Oxycodone hydrochloride	Opioid agonist	24
OxyContin	Opioid agonist	28
Pantoprazole	Proton pump inhibitor	13
Paroxetine hydrochloride	Serotonin reuptake inhibitor	12
Paxil	Serotonin reuptake inhibitor	34
Prednisone	Corticosteroid	11
Pregabalin		56
Promethazine	Phenothiazine	13
Propofol	General anesthetic	17
Prozac	Serotonin reuptake inhibitor	19
Quetiapine	Atypical antipsychotic	45
Quetiapine fumarate	Atypical antipsychotic	13
Ranitidine	Histamine-2 receptor antagonist	14
Reclast	Bisphosphonate	13
Relenza	Neuraminidase inhibitor	23
Rexulti	Atypical antipsychotic	14
Risperdal	Atypical antipsychotic	33
Risperidone	Atypical antipsychotic	51
Ritalin	Central nervous system stimulant	10
Sabril	Anti-epileptic agent	30
Sandostatin	Somatostatin analog	31
Sandostatin LAR Depot		19
Seroquel	Atypical antipsychotic	57
Sertraline	Serotonin reuptake inhibitor	31
Singulair	Leukotriene receptor antagonist	204
Spravato		21
Strattera	Norepinephrine reuptake inhibitor	63
Synagis	Respiratory syncytial virus Anti-F protein monoclonal antibody	12
Tamiflu	Neuraminidase inhibitor	83
Tegretol	Mood stabilizer	10
Topiramate		10
Tramadol		25
Trikafta		18
Trimipramine	Tricyclic antidepressant	12
Tysabri	Integrin receptor antagonist	12
Valproic acid	Anti-epileptic agent	10
Valtrex	Herpes simplex virus nucleoside analog DNA polymerase inhibitor	12
Venlafaxine	Serotonin and norepinephrine reuptake inhibitor	15
Venlafaxine hydrochloride	Serotonin and norepinephrine reuptake inhibitor	18
Viibryd		11
Vimpat		11
Vivitrol		17
Vyvanse	Central nervous system stimulant	25
Wellbutrin	Aminoketone	12
Xanax	Benzodiazepine	19
Xenazine	Vesicular monoamine transporter 2 inhibitor	13
Xyrem	Central nervous system depressant	69
Zoloft	Serotonin reuptake inhibitor	28
Zyprexa	Atypical antipsychotic	23

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 29 pharmacologic classes with 25 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Screaming name, in order of name
Class	Reports with this term
Aminoketone	64
Anti-epileptic agent	152
Aromatic amino acid	46
Atypical antipsychotic	705
Benzodiazepine	212
Central nervous system depressant	85
Central nervous system stimulant	116
Cholinesterase inhibitor	38
Contrast agent for ultrasound imaging	32
Corticosteroid	47
Fluoroquinolone antibacterial	26
gamma-Aminobutyric acid-ergic agonist	30
Histamine-1 receptor antagonist	49
Interleukin-4 receptor alpha antagonist	59
Leukotriene receptor antagonist	295
Mood stabilizer	25
Neuraminidase inhibitor	127
Nonsteroidal anti-inflammatory drug	77
Norepinephrine reuptake inhibitor	63
Opioid agonist	226
Osmotic laxative	67
Parathyroid hormone analog	29
Partial cholinergic nicotinic agonist	191
Progestin	25
Proton pump inhibitor	50
Serotonin and norepinephrine reuptake inhibitor	96
Serotonin reuptake inhibitor	204
Somatostatin analog	31
Tumor necrosis factor blocker	72

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Screaming, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Screaming
Age	Reports	Share
Under 2	335	5.3%
2 to 11	1,024	16.3%
12 to 17	242	3.8%
18 to 44	938	14.9%
45 to 64	941	14.9%
65 to 74	435	6.9%
75 and over	448	7.1%
Age not given	1,935	30.7%

Sex of the patient in the reports that record Screaming
Sex	Reports	Share
Female	3,590	57%
Male	2,286	36.3%
Unknown or not given	422	6.7%

Age and sex are as the report gives them. 73.2% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Screaming: adverse event reports that record this term. https://reportedreactions.com/reaction/screaming/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 29 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Screaming mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page